MX2014007031A - Terapia para hemorragia subaracnoidea e isquemia. - Google Patents
Terapia para hemorragia subaracnoidea e isquemia.Info
- Publication number
- MX2014007031A MX2014007031A MX2014007031A MX2014007031A MX2014007031A MX 2014007031 A MX2014007031 A MX 2014007031A MX 2014007031 A MX2014007031 A MX 2014007031A MX 2014007031 A MX2014007031 A MX 2014007031A MX 2014007031 A MX2014007031 A MX 2014007031A
- Authority
- MX
- Mexico
- Prior art keywords
- aneurysm
- subjects
- subarachnoid hemorrhage
- endovascular
- psd
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1021—Tetrapeptides with the first amino acid being acidic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
Abstract
La solicitud proporciona datos a partir de un ensayo clínico de un inhibidor de PSD-95 en sujetos que experimentan reparación endovascular de un aneurisma en o de otro modo que afecta el SNC. Los sujetos se estratificaron en función de si el aneurisma se rompió antes de realizar la cirugía endovascular. La ruptura se asoció con mayor mortalidad o debilidad incrementada si el sujeto sobrevivió. El ensayo proporcionó evidencia de beneficio significativo en sujetos con y sin ruptura del aneurisma antes de que se realizara la cirugía endovascular. De manera sorprendente los sujetos que se beneficiaron más del tratamiento según se juzgó tanto por la patología como por el resultado neurocognitivo fueron aquellos en los cuales el aneurisma se rompió causando una hemorragia subaracnoidea. Estos datos constituyen la evidencia de que un inhibidor de PSD-95 es benéfico no solo en isquemia y choque hemorrágico sino en formas de hemorragia en o que afectan el SNC, particularmente hemorragia subaracnoidea.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161570264P | 2011-12-13 | 2011-12-13 | |
| CA2762338A CA2762338C (en) | 2011-12-13 | 2011-12-15 | Therapy for subarachnoid hemorrhage and ischemia |
| US201261617001P | 2012-03-28 | 2012-03-28 | |
| PCT/IB2012/057259 WO2013088382A1 (en) | 2011-12-13 | 2012-12-13 | Therapy for subarachnoid hemorrhage and ischemia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2014007031A true MX2014007031A (es) | 2015-02-20 |
| MX364562B MX364562B (es) | 2019-04-30 |
Family
ID=51228598
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2014007031A MX364562B (es) | 2011-12-13 | 2012-12-13 | Terapia para hemorragia subaracnoidea e isquemia. |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP2800575B1 (es) |
| JP (3) | JP6279483B2 (es) |
| KR (2) | KR20200057802A (es) |
| CN (1) | CN104053448B (es) |
| AU (1) | AU2012354072B2 (es) |
| DK (1) | DK2800575T3 (es) |
| ES (1) | ES2731266T3 (es) |
| IL (1) | IL233103B (es) |
| MX (1) | MX364562B (es) |
| SG (2) | SG11201403239UA (es) |
| WO (1) | WO2013088382A1 (es) |
| ZA (1) | ZA201404636B (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2440230T3 (pl) | 2009-06-10 | 2021-06-14 | Nono Inc. | Schematy leczenia do leczenia choroby neurologicznej |
| PL2723363T3 (pl) | 2011-06-24 | 2018-12-31 | Nono Inc. | Leczenie skojarzone niedokrwienia |
| US9241970B2 (en) | 2011-12-13 | 2016-01-26 | Nono Inc. | Therapy for subarachnoid hemorrhage and ischemia |
| CN106661126B (zh) | 2014-05-28 | 2021-12-10 | 诺诺公司 | TAT-NR2B9c的氯盐 |
| CN107312071B (zh) * | 2016-04-27 | 2018-11-06 | 拜西欧斯（北京）生物技术有限公司 | 兴奋性神经毒性相关损伤的治疗方法 |
| KR20180135493A (ko) * | 2016-04-27 | 2018-12-20 | 바이오셀즈(베이징) 바이오테크 코., 엘티디. | 흥분성 신경독성 관련 손상의 치료 방법 |
| CN109985047B (zh) * | 2017-12-29 | 2021-07-27 | 广州市赛普特医药科技股份有限公司 | 5α-雄甾-3β,5,6β-三醇在制备治疗出血性脑卒中药物中的应用 |
| CN109009111A (zh) * | 2018-07-16 | 2018-12-18 | 重庆大学 | 低场核磁共振脑出血动态监护仪控制系统 |
| CN113284126B (zh) * | 2021-06-10 | 2022-06-24 | 安徽省立医院(中国科学技术大学附属第一医院) | 人工神经网络图像分析预测脑积水分流手术疗效的方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7510824B2 (en) | 1999-06-02 | 2009-03-31 | Nono Inc. | Method of screening peptides useful in treating traumatic injury to the brain or spinal cord |
| EP1884521A1 (en) * | 2006-07-31 | 2008-02-06 | Xigen S.A. | Fusion peptide for inhibiting interaction of neuronal NMDA receptor (NMDAR) and NMDAR interacting proteins |
| ES2446292T3 (es) * | 2007-03-02 | 2014-03-07 | Nono Inc. | Tratamiento del accidente cerebrovascular y otras enfermedades sin inhibir los canales de calcio de tipo N |
| PL2440230T3 (pl) | 2009-06-10 | 2021-06-14 | Nono Inc. | Schematy leczenia do leczenia choroby neurologicznej |
-
2012
- 2012-12-13 AU AU2012354072A patent/AU2012354072B2/en active Active
- 2012-12-13 ES ES12857611T patent/ES2731266T3/es active Active
- 2012-12-13 SG SG11201403239UA patent/SG11201403239UA/en unknown
- 2012-12-13 JP JP2014546717A patent/JP6279483B2/ja active Active
- 2012-12-13 MX MX2014007031A patent/MX364562B/es active IP Right Grant
- 2012-12-13 DK DK12857611.3T patent/DK2800575T3/da active
- 2012-12-13 SG SG10201604676WA patent/SG10201604676WA/en unknown
- 2012-12-13 WO PCT/IB2012/057259 patent/WO2013088382A1/en active Application Filing
- 2012-12-13 CN CN201280061924.1A patent/CN104053448B/zh active Active
- 2012-12-13 KR KR1020207014227A patent/KR20200057802A/ko not_active Application Discontinuation
- 2012-12-13 EP EP12857611.3A patent/EP2800575B1/en active Active
- 2012-12-13 KR KR1020147019192A patent/KR102114490B1/ko active IP Right Grant
-
2014
- 2014-06-12 IL IL233103A patent/IL233103B/en active IP Right Grant
- 2014-06-24 ZA ZA2014/04636A patent/ZA201404636B/en unknown
-
2017
- 2017-11-10 JP JP2017217549A patent/JP6741642B2/ja active Active
-
2020
- 2020-05-15 JP JP2020085748A patent/JP2020128419A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IL233103A0 (en) | 2014-07-31 |
| ZA201404636B (en) | 2015-10-28 |
| SG10201604676WA (en) | 2016-07-28 |
| EP2800575A4 (en) | 2015-09-23 |
| KR20140108266A (ko) | 2014-09-05 |
| AU2012354072A1 (en) | 2014-07-03 |
| CN104053448B (zh) | 2017-04-05 |
| CN104053448A (zh) | 2014-09-17 |
| JP6741642B2 (ja) | 2020-08-19 |
| KR102114490B1 (ko) | 2020-05-25 |
| JP2020128419A (ja) | 2020-08-27 |
| AU2012354072B2 (en) | 2017-04-27 |
| ES2731266T3 (es) | 2019-11-14 |
| WO2013088382A1 (en) | 2013-06-20 |
| MX364562B (es) | 2019-04-30 |
| EP2800575A1 (en) | 2014-11-12 |
| JP2018052962A (ja) | 2018-04-05 |
| KR20200057802A (ko) | 2020-05-26 |
| JP6279483B2 (ja) | 2018-02-14 |
| SG11201403239UA (en) | 2014-09-26 |
| DK2800575T3 (da) | 2019-07-01 |
| EP2800575B1 (en) | 2019-05-22 |
| IL233103B (en) | 2021-03-25 |
| JP2015501834A (ja) | 2015-01-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX364562B (es) | Terapia para hemorragia subaracnoidea e isquemia. | |
| IL260297A (en) | Process for preparing n-[5-(5,3-difluoro-benzyl)-h1-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydro-pyran-4-ylamino )–benzamide | |
| BR112014024287A2 (pt) | composições e métodos para a prevenção e tratamento do derrame vascular induzido por mastócitos | |
| MX2022002786A (es) | Inhibidores del reciclaje de acidos biliares para el tratamiento de colangitis esclerosante primaria y enfermedad inflamatoria intestinal. | |
| MX2008013454A (es) | Metodos y equipos para la prediccion de riesgo en partos prematuros. | |
| ES2577145T3 (es) | Tornillo y procedimiento para producir una rosca de tornillo | |
| BR112015004191A2 (pt) | chapa de aço | |
| SG10201510118VA (en) | Use of refrigerants comprising e-1,3,3,3-tetrafluoropropene and at least one tetrafluoroethane for cooling | |
| GB2528801A (en) | Compositions and their use to treat complications of aneurysmal subarachnoid hemorrhage | |
| MY148893A (en) | Combination of an hdac inhibitor and an antimetabolite | |
| MY185054A (en) | Rolled collagen carrier | |
| Boricha et al. | Laparoscopy in 50 infertile couples: prospective study | |
| WO2006026557A3 (en) | Methods and kits for predicting risk for peterm labor | |
| EP2571504A4 (en) | USE OF AROMATASE INHIBITORS FOR SYNCHRONIZED EASPING, FOR MAKING MULTIPLE OR DOUBLE EISPRUS, AND FOR INCREASING TWINING AND FRUITABILITY OF MAMMALS | |
| NZ611614A (en) | Compositions and methods for treating amyloid plaque associated symptoms | |
| FR2964553B1 (fr) | Systeme de traitement chirurgical pour realiser une anastomose entre la vessie et l'uretre | |
| RU2012149809A (ru) | Способ прогнозирования прогрессирования первичной открытоугольной глаукомы | |
| Macdonald | Whether subarachnoid hemorrhage depends on the weather? | |
| UA62588U (ru) | Способ хирургического лечения артериовенозных мальформаций головного мозга | |
| Macdonald | Dissecting the complexities of aneurysm hemodynamics | |
| 郭建明 | Surgical treatment of visceral artery aneurysms | |
| PH12015501458A1 (en) | A use of the mixture of a salt and sugar in the manufacture of a medicament employed for treating lax vagina syndrome or colpoxerosis disease in a mammal | |
| FR2963832B1 (fr) | Procede de quantification de l'effet potentialisateur du fibrinogene sur la generation de thrombine et ses applications | |
| RU2012144141A (ru) | Способ оценки вероятности возникновенения переломов при остеопорозе у женщин | |
| UA84482C2 (ru) | Способ неотложного хирургического лечения пациентов с идиопатической тромбоцитопенической пурпурой, осложненной внутрибрюшным кровотечением |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |